iCAD showcases Breast AI suite at SBI Symposium

iCAD announced it will showcase its Breast AI Suite of cancer detection, density assessment and risk evaluation solutions at the world’s largest breast imaging conference, the Society of Breast Imaging, SBI, Symposium, taking place May 4-7 in National Harbor, MD. "While mammography screening has improved in recent decades and the introduction of digital breast tomosynthesis offers many clinical advantages, it also creates enormous amounts of data. Processing this volume of data can weigh heavily on radiologists and imaging teams," said Dana Brown, President and CEO of iCAD, Inc. "iCAD’s Breast AI Suite offers a 360-degree solution of cancer detection, density assessment, and risk evaluation technologies that are uniquely positioned to address the top challenges clinicians face today. Not only is our solution clinically proven to improve accuracy and efficiency for radiologists reading mammography, it offers critical information about a woman’s present and future breast health, which can help clinicians find more interval breast cancers at their earliest stage possible."